Literature DB >> 30106436

Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.

Pukkavadee Netsirisawan1, Parunya Chaiyawat2, Daranee Chokchaichamnankit1, Kriengsak Lirdprapamongkol1, Chantragan Srisomsap1, Jisnuson Svasti1, Voraratt Champattanachai1.   

Abstract

O-GlcNAcylation is a dynamic posttranslational modification of nucleoplasmic proteins. Previously, we reported that the O-GlcNAcylation level was increased in primary breast and colorectal cancer tissues. However, its precise roles in cancer development and progression are still largely unexplored. The aim of the present study was to investigate the roles of O-GlcNAcylation in the malignant transformation of cancer cell lines. O-GlcNAcylation level was examined in six cancer cell lines including breast (MCF-7 and MDA-MB-231), colorectal (SW480 and SW620), and liver (SK-Hep1 and HepG2). We found that the levels of O-GlcNAcylation and O-GlcNAc transferase (OGT), an O-GlcNAc catalyzing enzyme, were obviously increased in all cancerous cells, except SK-Hep1, when compared to normal cells. Reducing O-GlcNAcylation using RNA interference against OGT showed a marked reduction in OGT and O-GlcNAcylation levels. Surprisingly, siOGT had no effect on cell growth under conventional monolayer cultures. However, it inhibited anchorage-independent growth in soft agar cultures of all cancer cells, except SK-Hep1. Under anoikis resistance conditions performed by spheroid cultures, siOGT treatment decreased viability only in MCF-7, SW480, and SW620 cells. Among them, OGT knockdown in MCF-7 cells revealed a high inhibitory effect on colony and spheroid cultures. Using two-dimensional gel electrophoresis and mass spectrometric analysis, heat shock protein 27 (Hsp27) was found to be the highest upregulated protein upon OGT knockdown. Immunoblots revealed that the Hsp27 protein level was increased but its O-GlcNAc modification level was decreased in siOGT-treated cells. These changes were associated with the inhibition of MCF-7 cell transformation. Notably, double knockdown of OGT and Hsp27 showed a reversal in the inhibitory effect on colony and spheroid cultures. Collectively, these results indicate that O-GlcNAcylation is required for anoikis resistance and anchorage-independent growth of MCF-7 cells. Blocking this glycosylation by OGT knockdown may regulate both Hsp27 protein expression and its O-GlcNAc modification levels. This alteration may play vital roles in malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30106436     DOI: 10.3892/or.2018.6617

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Global profiling of O-GlcNAcylated and/or phosphorylated proteins in hepatoblastoma.

Authors:  Hang Song; Ji Ma; Zhixuan Bian; Shuhua Chen; Jiabei Zhu; Jing Wang; Nan Huang; Minzhi Yin; Fenyong Sun; Min Xu; Qiuhui Pan
Journal:  Signal Transduct Target Ther       Date:  2019-10-11

Review 2.  Targeting O-GlcNAcylation to overcome resistance to anti-cancer therapies.

Authors:  Ninon Very; Ikram El Yazidi-Belkoura
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

3.  Quantitative proteomic analysis of the association between decreasing O‑GlcNAcylation and metastasis in MCF‑7 breast cancer cells.

Authors:  Pukkavadee Netsirisawan; Daranee Chokchaichamnankit; Kittirat Saharat; Chantragan Srisomsap; Jisnuson Svasti; Voraratt Champattanachai
Journal:  Int J Oncol       Date:  2020-03-20       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.